One patient with lung carcinoid with Ki-67 < 5% without evidence of an inherited syndrome had somatic mutations detected including PDGFRB A366T and CDKN1b loss, and had best response of stable disease on treatment. Here, PDGFRB is linked to lung carcinoid tumor.